Pulmonary arterial hypertension is a complex pathology whose etiology is still not
completely well clarified. The pathogenesis of pulmonary arterial hypertension involves …

Pulmonary hypertension (PH) is a fatal disease caused by progressive pulmonary vascular
remodeling (PVR). Currently, the mechanisms underlying the occurrence and progression of …

Pulmonary arterial hypertension (PAH) is a severe cardiovascular disease characterized by
elevated pulmonary vascular resistance, progressive increases in pulmonary artery …

Pulmonary arterial hypertension (PAH) is a progressive disorder caused by the narrowing of
small blood vessels in the lungs, which, in the absence of therapies, leads to right heart …

Pulmonary arterial hypertension (PAH) is a debilitating vascular disorder characterized by
abnormal pulmonary artery smooth muscle cell (PASMC) proliferation and collagen …

Individuals residing in plateau regions are susceptible to pulmonary hypertension (PH) and
there is an urgent need for a prediction nomogram to assess the risk of PH in this population …

Persistent Pulmonary Hypertension of the Newborn (PPHN) is a life-threatening condition
characterized by the failure of normal circulatory transition after birth, leading to sustained …

The natriuretic peptide system (NPS) is the key driving force of the heart's endocrine
function. Recent developments in NPS-targeted therapies have been found promising and …

It is a complex disease with multiple pathogenesis that causes pulmonary hypertension
(PH). In addition to the commonly used drugs for treating PH, pharmacogenomic therapies …

Abnormal proliferation and migration of pulmonary artery smooth muscle cells (PASMCs)
leading to pulmonary vascular remodeling are critical factors in the development of …